Meet the Professor Lunch Sessions

We are delighted to invite you to informal lunch sessions with the professors.

Diane Bovenkamp, USA
HOW TO APPLY FOR FUNDING FROM A NONPROFIT ORGANIZATION

SOLD OUT

Alison Goate, USA
BUILDING A PIPELINE FROM GENETICS TO DRUG DISCOVERY

SOLD OUT

Todd Golde, USA
ENJOYING WORK AND LIFE AS A SCIENTISTS WHILE ADVANCING YOUR CAREER

SOLD OUT

Tiago Outerio, Germany
BIOLOGICAL CLASSIFICATION OF PARKINSON’S DISEASE: WHY DOES IT MATTER FOR BASIC RESEARCH?

SOLD OUT

Peter St. George-Hyslop, Canada
THE ROLE OF INTRINSICALLY DISORDERED / LOW COMPLEXITY PROTEINS AND THEIR FORMATION OF BIOMOLECULAR CONDENSATES IN NEURODEGENERATION

SOLD OUT

Stephen Salloway, USA
SAFE USE OF AMYLOID-LOWERING TREATMENT IN THE CLINICBart De Strooper, Belgium
CHALLENGES IN ALZHEIMER’S RESEARCH

SOLD OUT

Marc Diamond, USADEVELOPING A HYPOTHESIS TO STUDY NEURODEGENERATION

SOLD OUT

Angela Genge, Canada
BIOMARKER PROGRESS IN ALS

SOLD OUT

Frank Laferla, USAFACILITATING SUCCESS IN ACADEMIA AND AVOIDING PITFALLSMelissa Murray, USAHOW TO DEAL WITH IMPOSTER SYNDROME

SOLD OUT

Agneta Nordberg, Sweden
FLUID AND IMAGING BIOMARKERS IN ALZHEIMER´S DISEASE

SOLD OUT

Werner Poewe, Austria
WHAT IS PARKINSON’S DISEASE – EVOLVING DIAGNOSTIC CONCEPTS

SOLD OUT

Sam Sisodia, USA
PERIPHERAL INFLUENCES ON BRAIN (DYS)FUNCTION IN AD

SOLD OUT

Donna Wilcock, USA
THE IMPORTANCE OF MULTIPLE MENTORS FOR ACADEMIC CAREER PROGRESSIONLuc Buee, France
INTRACELLULAR OR EXTRACELLULAR TAU: WHICH THERAPEUTIC TARGETS?

SOLD OUT

Michael Heneka, Luxenmburg
NEUROINFLAMMATION

SOLD OUT

Nick Fox, United Kingdom
PROSPECTS AND CHALLENGES FOR ANTI-AMYLOID IMMUNOTHERAPIES FOR ALZHEIMER’S DISEASE

SOLD OUT

Walter J. Koroshetz, USANIH FUNDING MECHANISMS FOR PD AND THE ALZHEIMER RELATED DEMENTIAS

SOLD OUT

Laura Ranum, USAREPEAT ASSOCIATED NON-AUG (RAN) PROTEINS IN NEURODEGENERATIVE DISEASE: MOLECULAR MECHANISMS AND THERAPEUTIC STRATEGIES

SOLD OUT

Philip Scheltens, The NetherlandsEARLY DIAGNOSIS: CONCEPT AND TOOLS

SOLD OUT

Fabrizio Stocchi, Italy
PARKINSON DISEASE: TODAY AND TOMORROW

SOLD OUT

Li-Huei Tsai, USAUSING HUMAN IPSCS AND TISSUE ENGINEERING APPROACHES TO MODEL ALZHEIMER’S DISEASE

SOLD OUT

Jie Shen, USAHOW TO BUILD A SUCCESSFUL ACADEMIC CAREERCharlotte Teunissen, The Netherlands
CAREER DEVELOPMENT FOR FEMALES

SOLD OUT

Joachim Herz, USA
DYSREGULATION OF ENDOLYSOSOMAL ACIDIFICATION AS A ROOT CAUSE OF ALZHEIMER’S DISEASE

SOLD OUT

Robert Vassar, USA
THE TREATMENT OF ALZHEIMER’S DISEASE: PAST, PRESENT, AND FUTURE

SOLD OUT

There is a €15 fee for joining each session and pre-registration is required.
Please, note that for each session there are a maximum of 9 seats available and you can join only 1 session per day.

You can book your seat during the registration process or if you are already registered, please contact us at reg_adpd23@kenes.com.

REGISTER HERE